mefloquine has been researched along with bortezomib in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boddey, JA; Cowman, AF; Czabotar, PE; de Lezongard, RB; Hodder, AN; Jarman, KE; Jousset Sabroux, H; Nguyen, W; O'Neill, MT; Sleebs, BE; Thompson, JK | 1 |
| Enomoto, S; Hamano, T; Kitazaki, Y; Morita, M; Nakamichi, K; Usui, K | 1 |
1 review(s) available for mefloquine and bortezomib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for mefloquine and bortezomib
| Article | Year |
|---|---|
Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P
Topics: Amino Acids; Antimalarials; Aspartic Acid Endopeptidases; Dose-Response Relationship, Drug; Molecular Structure; Parasitic Sensitivity Tests; Peptidomimetics; Plasmodium falciparum; Protease Inhibitors; Structure-Activity Relationship | 2018 |
[A case of progressive multifocal leukoencephalopathy associated with daratumumab, bortezomib, and dexamethasone for multiple myeloma].
Topics: Aged, 80 and over; Bortezomib; Dexamethasone; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Mirtazapine; Multiple Myeloma | 2023 |